AMSilk GmbH
AMSilk grows with additional capital – ramp-up of BIOSTEEL(R) production
DGAP-News: AMSilk GmbH / Key word(s): Financing ———– PRESS RELEASE ———– AMSilk grows with additional capital – ramp-up of BIOSTEEL(R) production “We very much appreciate the trust and confidence which our longtime investors AT Newtec and MIG show us with their add-on investments. For us this is a wonderful confirmation that our products are valued by the market and that they have a promising future. After many years of development we are now in the phase of commercializing our products including AMSilk high-performance biopolymers for use in medical technology, cosmetic and personal care products as well as our BIOSTEEL(R) fibers in industrial applications & textiles”, states Jens Klein, CEO of AMSilk. “AMSilk and its innovative product idea of using a biotechnological process to develop an organic high-performance material modelled on spider silk has convinced us from the beginning. The company has already introduced a number of products and applications into the market and is ready to launch further products. During the current round of financing we thus did not hesitate to continue investing in the company in order to be able to participate in the future success of AMSilk”, says Dr. Matthias Kromayer, Member of the Executive Board of MIG and Deputy Chairman of the Supervisory Board of AMSilk. Capital to be used for funding further growth and product development Together with a leading European manufacturer of breast implants, AMSilk plans to conduct a clinical study on breast implants coated with AMSilk silk biopolymers. The market introduction of the silk-coated breast implants, whose tolerability is significantly higher compared to conventional breast implants, is expected to take place already in 2017. Additionally, AMSilk plans further investments in the field of application technology to use the AMSilk high-performance biopolymers in cosmetic ingredients as well as to further enhance the patent position of the company, which currently includes more than 20 patent families. About the investors About AMSilk AMSilk high-performance biopolymers are distributed in the form of Silkbeads (microparticles), Silkgel (hydrogel) or BIOSTEEL(R) (fibers). They are currently used in coatings for medical technology products, in the textile industry and as an ingredient in personal care products. www.amsilk.com For further information please contact: AMSilk GmbH Kirchhoff Consult AG
2016-07-11 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |